Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$2.51M Buy
41,624
+6,009
+17% +$306K 0.03% 496
2014
Q4
$1.56M Buy
35,615
+80
+0.2% +$3.53K 0.02% 599
2014
Q3
$1.6M Buy
35,535
+2,590
+8% +$138K 0.02% 516
2014
Q2
$2.44M Buy
32,945
+3,300
+11% +$260K 0.03% 430
2014
Q1
$2.46M Sell
29,645
-962
-3% -$84.5K 0.04% 425
2013
Q4
$4.23M Sell
30,607
-4,107
-12% -$484K 0.07% 292
2013
Q3
$3.32M Sell
34,714
-20,563
-37% -$1.75M 0.06% 336
2013
Q2
$3.38M Buy
+55,277
New +$3.07M 0.07% 306

Other funds holding NUS

Baird's NUS Position: Q1 2015 in Review

Baird increased its Nu Skin (NUS) stake by 17% in Q1 2015, buying an estimated $306K and bringing the position to 41,624 shares worth $2.51M. The position accounts for 0.03% of the portfolio, ranked #496.

Baird first reported a position in NUS in Q2 2013 and has held it in 8 quarters since. The position peaked at $4.23M in Q4 2013. 203 funds tracked by Wall St. Rank hold NUS as of Q1 2015.

  • Baird held 41,624 shares of Nu Skin worth $2.51M as of Q1 2015.
  • Baird bought 6,009 Nu Skin shares in Q1 2015, an estimated $306K.
  • Nu Skin made up 0.03% of Baird's portfolio in Q1 2015, its #496 holding.
  • Baird first reported a position in Nu Skin in Q2 2013 and has held it in 8 quarters since.
  • Baird's Nu Skin position peaked at $4.23M in Q4 2013.
  • 203 funds tracked by Wall St. Rank held Nu Skin as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.